[1]
Caicedo Valle, J. et al. 2016. The risk of 2,5-dimethoxy-4-bromophenylethylamine (2C-B): Case series. Medicina UPB. 35, 2 (Dec. 2016), 139–143. DOI:https://doi.org/10.18566/medupb.v35n2.a08.